The Korean Journal of Blood Transfusion : eISSN 2383-6881 / pISSN 1226-9336

Table. 2.

Table. 2.

Review of the cases regarding antibodies to high-incidence red blood cell antigens reported in Korea

AntibodyNumber of case(s)HTR/HDFNCharacteristicsReference(s)
anti-JMH1nonehigh-titer, low-avidity[9]
anti-Ge2N/A*sensitive to papain (Ge2, Ge4: sensitive to papain, Ge3: resistant to papain)[10,11]
anti-Jra4HDFNresistant to papain and DTT[12-15]
anti-Dib7HDFNresistant to papain and DTT Di(a–b+): most common in Koreans[16-21]
anti-Ku1HTRseen in immunized persons with the Knull phenotype by transfusion or pregnancy[22]
anti-Oka1N/A*resistant to papain and DTT[23]
anti-Sda1nonemixed-field agglutination proven by urine neutralization[24]
anti-Yka1nonehigh-titer, low-avidity[25]
anti-Csa2nonehigh-titer, low-avidity[26]
anti-PP1Pk2N/A*naturally occurring antibody[27]
anti-Rh175HDFN, hydrops fetalisantibody to CcEe antigens[28-33]
anti-Fya2HTRFy(a+b–): most common in Koreans[34,35]

The cases have not received blood transfusion.

Abbreviations: DTT, dithiothreitol; HDFN, hemolytic disease of the fetus and newborn; HTR, hemolytic transfusion reaction; N/A, not applicable.

Korean J Blood Transfus 2019;30:101-12
© 2019 Korean J Blood Transfus